CLINICAL_TRIALS
trial_result
· 2024-07-18
Clinical Trial Update: A Multiple Ascending Dose Study of Milademetan in Subjects With Advanced Solid Tumors or Lymphomas [Phase 1]
Summary
Phase 1 multiple ascending dose study of milademetan in adults with advanced solid tumors or lymphomas has completed, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daiichi Sankyo | Conditions: Advanced Solid Tumor, Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2024-07-18